1 / 1

Comparison of Memory Scores in HIV-Infected and Uninfected Children at Week 144 of PREDICT Study

This figure presents memory scores from the Stanford-Binet II test assessing beads, objects, digits, and sentences. The comparison is made between HIV-infected children receiving early versus deferred antiretroviral therapy at week 144 of the PREDICT study, alongside a control group of HIV-uninfected children (both exposed and unexposed). Mean scores and standard deviations are indicated, with P-values adjusted for various demographic factors like caregiver education and income. Results reveal significant differences illustrating the impact of therapy timing on memory development in affected children.

judson
Télécharger la présentation

Comparison of Memory Scores in HIV-Infected and Uninfected Children at Week 144 of PREDICT Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure: Supplemental Digital Content 1 Figure: Stanford Binet II memory scores for beads, objects, digits and sentences comparing the HIV-infected children (early vs. deferred antiretroviral therapy arms) at week 144 of PREDICT and the HIV-uninfected (HIV-exposed and –unexposed) control group children. Footnote: Mean (standard deviation) scores are shown. P values for the comparison between PREDICT children and the uninfected HIV-exposed and HIV-unexposed negative controls have been adjusted for parent as caregiver, educational level of caregiver and income. The number of children in each group: HIV-infected/early antiretroviral therapy arm (n=80), HIV-infected/deferred antiretroviral therapy arm (n=81), HIV-uninfected/exposed (n=92) and HIV-uninfected/unexposed (n=102). P value represents significant differences between each of the HIV-uninfected groups relative to the combined early and deferred groups.

More Related